Rituximab in Combination with Cyclophosphamide, Mitoxantrone, Vincristine and Prednisone (R-CNOP) As First Line Regimen in Elderly Patients with Diffuse Large B-Cell Lymphoma

R-CNOP was shown to be an effective and safe regimen in elderly patients with diffuse large B-cell lymphoma. The majority of the patients had long term disease control. Hematological toxicity was common